ASCO and the Union for International Cancer Control (UICC) announced their partnership to expand the reach of the Journal of Global Oncology (JGO), a new open-access journal that will focus on cancer care, research, and care delivery issues unique to countries and settings with limited health-care resources.
It is estimated that today nearly two-thirds of all cancer deaths occur in low- and middle-income countries, and this is forecast to increase to 70% by 2030.1 While some journals publish special issues and sections focused on global oncology, JGO will be the first peer-reviewed journal dedicated solely to this area of research.
The partnership between ASCO, which boasts more than 35,000 members around the world, and UICC, whose membership represents more than 800 organizations in 155 countries, will extend the reach of JGO to a broad international audience. ASCO and UICC will work together to solicit high-quality original research, secure funding, and promote JGO to their respective networks.
Through this collaboration, ASCO and UICC will meet a growing need for high-quality clinical cancer research in low- and middle-income countries by providing a peer-review platform focused on the challenges faced by researchers and care providers in these countries.
“ASCO is committed to conquering cancer through research, education, prevention, and delivery of high quality patient care, and this aligns closely with UICC’s efforts to unite the cancer community to reduce the global cancer burden,” said David Kerr, MD, DSc, JGO’s founding Editor-in-Chief. “This partnership will amplify the impact of the Journal of Global Oncology in support of both organizations’ missions and will give a voice to those clinicians who practice cancer medicine in challenging conditions.”
JGO is funded through the Conquer Cancer Foundation of ASCO, with the support of the Doris Duke Charitable Foundation and Novartis Oncology. ■
Reference
1. International Agency for Research on Cancer, GLOBOCAN, 2012.
